$1.01
-0.04 (-3.81%)
Open$1.03
Previous Close$1.05
Day High$1.06
Day Low$1.01
52W High$1.57
52W Low$0.69
Volume—
Avg Volume40.1K
Market Cap55.54M
P/E Ratio—
EPS$-0.26
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+2,487.1% upside
Current
$1.01
$1.01
Target
$26.13
$26.13
$16.33
$26.13 avg
$37.99
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 36.7K | 146.1K | 15.27M |
| Net Income | -17,652,035 | -63,294,149 | 4.70M |
| Profit Margin | -51,035.7% | -48,483.9% | 30.8% |
| EBITDA | -16,656,521 | -63,042,609 | 6.30M |
| Free Cash Flow | — | — | 4.04M |
| Rev Growth | -74.9% | -74.9% | -3.4% |
| Debt/Equity | — | — | 0.36 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,364.73 | -3.76% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $272.32 | -1.45% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $146.94 | -2.27% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.88 | -2.96% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $63.13 | -1.65% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $82.11 | -7.95% | 12.3 | 32.24B |